SUBSCRIBE
SUBSCRIBE

Puerto Rico

Businessman pushing boulder uphill vector concept of Sisyphus. Symbol of hard work, futile effort, strength, struggle, challenge but also motivation and ambition. Eps10 vector illustration.
Manufacturing
As Amgen and Lilly Recommit, Puerto Rico Seeks To Regain Manufacturing Momentum
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
February 3, 2026
 · 
4 min read
 · 
Nick Paul Taylor
PRESS RELEASES
Press Releases
Pharma-Bio Serv Announces Full Year Results and Special Dividend - January 29, 2026
January 30, 2026
 · 
3 min read
Press Releases
Adaptin Bio to Present at the 2026 Sequire Investor Summit in Puerto Rico
January 16, 2026
 · 
3 min read
Press Releases
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States
October 30, 2025
 · 
6 min read
Press Releases
Aphaia Pharma Publishes Phase 1 and 2 Clinical Data of Oral Formulation in Patients with Obesity and Prediabetes
September 24, 2025
 · 
5 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2025
June 17, 2025
 · 
2 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
May 28, 2025
 · 
7 min read
Press Releases
IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market
May 23, 2025
 · 
4 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
May 20, 2025
 · 
4 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21
May 8, 2025
 · 
2 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 30, 2025
 · 
5 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
 · 
3 min read
Press Releases
Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
April 10, 2025
 · 
6 min read
Press Releases
Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin
March 20, 2025
 · 
5 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2025
March 18, 2025
 · 
2 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
March 13, 2025
 · 
6 min read
Press Releases
Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin
February 26, 2025
 · 
6 min read
Press Releases
Hemostemix PR Inc. Congratulates Luis Munoz Marin International Airport on Achieving CEIV Pharma Certification
February 11, 2025
 · 
6 min read
Press Releases
Pharma-Bio Serv Announces Full Year Results
January 30, 2025
 · 
3 min read
Press Releases
Pharma-Bio Serv Announces Special Dividend
January 30, 2025
 · 
2 min read
Press Releases
Happen Ventures Helps Honest Medical Divert Surplus Medical Supplies
January 15, 2025
 · 
2 min read
Load More